About Avalanche Biotechnologies, Inc. (adapted from Avalanche Biotechnologies, Inc. prospectus):
They are a clinical-stage biotechnology company focused on discovering and developing novel gene therapies to transform the lives of patients with sight-threatening ophthalmic diseases.

This description is adapted from Avalanche AAVL prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.